OUTLOOK THERAPEUTICS INC
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -38.7% | +0.0% | +0.0% | +857.3% | -73.4% | +0.0% | +0.0% | +0.0% | +38.4% | -40.0% | -8.9% | +902.7% | 0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | -106.1% | – | – | -92.9% | – | |
| – | +241.5% | +31,025.7% | +1.0% | -44.6% | -82.5% | +1,181.3% | +12.4% | +23.3% | -15.1% | -99.9% | -26.8% | +71.7% | -21.6% | +2,914.8% | -30.6% | -93.8% | +56.7% | +588.7% | -41.4% | +5.2% | +0.4% | +0.4% | +0.4% | +0.4% | -79.1% | +2.1% | +1.7% | +0.2% | +151.4% | +0.0% | +1.7% | +0.4% | +0.0% | +1.0% | +1,411.3% | +108.4% | -96.8% | +404.0% | -88.6% | – | |
| – | -41.0% | +3.1% | 0.0% | +99.7% | -38.1% | +107.5% | -0.1% | -0.2% | +38.8% | -40.2% | -8.7% | +908.8% | -100.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -194.6% | – | – | – | – | |
| – | +214.1% | -68.9% | +1.0% | -50.5% | -80.5% | +1,181.3% | +12.4% | +23.3% | -15.1% | -2.2% | -26.8% | +3.5% | +30.1% | -25.0% | +93.7% | -10.2% | +56.7% | -28.6% | +0.2% | +16.3% | -0.6% | +23.8% | -7.9% | -20.1% | +9.7% | -94.5% | +1,937.3% | -55.5% | -8.4% | +198.3% | -17.1% | +11.8% | -22.9% | -54.4% | +61.9% | -16.2% | -39.2% | +23.8% | -27.8% | – | |
| – | -26.7% | -17.4% | -13.5% | -1.1% | +3.0% | -31.1% | -10.3% | +174.9% | -51.9% | -36.3% | -0.8% | +51.6% | -16.0% | -16.3% | +68.0% | -27.3% | -6.2% | +82.7% | -28.5% | +19.5% | -6.4% | +104.1% | -13.7% | -13.5% | +16.6% | +8.0% | +11.9% | +6.7% | -22.9% | -6.3% | +53.9% | +23.8% | +15.4% | -33.2% | +21.2% | +6.7% | -16.6% | +10.4% | -20.6% | – | |
| – | -25.9% | -17.4% | -13.5% | +0.7% | +1.2% | -31.1% | +226.6% | -24.5% | -13.0% | +48.2% | -20.7% | +17.8% | +12.5% | -26.7% | +80.1% | -7.3% | +41.7% | -11.0% | -9.1% | +17.1% | -2.1% | +43.8% | -10.0% | -17.8% | +12.2% | -56.4% | +165.3% | -31.3% | -17.1% | +83.5% | +3.3% | +16.8% | -5.6% | -42.6% | +35.7% | -3.0% | -24.9% | +14.4% | -22.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +111.2% | +154.3% | +40.4% | +41.0% | -70.8% | +28.3% | +24.6% | -3.7% | +1.4% | -6.0% | +2.7% | -80.6% | +184.4% | +16.5% | -36.3% | -95.7% | +739.0% | +56.8% | +2.6% | +4.8% | +30.6% | +19.0% | -14.7% | +1.0% | +578.9% | +7,669,372.0% | -100.0% | +707,185,990,329.0% | +0.0% | -100.0% | -100.0% | – | – | – | +166.7% | +435.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -87.2% | +205.3% | -366.7% | – | – | – | – | – | – | |
| – | – | +28,397.6% | +43.7% | -69.6% | -733.4% | – | +70,868,969.5% | -100.0% | – | -100.0% | -427.2% | – | – | +64.7% | -569.9% | – | – | -98.7% | -9,023.7% | – | – | -99.4% | -100.1% | – | +0.0% | +250.0% | -14,178.3% | – | -100.0% | – | -100.1% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -87.2% | +205.3% | -366.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.